GGrantIndex
Sort

23,748 grants matching melanoma

Signaling importance of ‘functionless’ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras

$407,027
Jing Chen · University Of Chicago · R01 · FY2022 · CA

PSM Moffitt Cancer Center Partnership

$407,009
Jose A Torres-Ruiz · Ponce School Of Medicine · U56 · FY2010 · CA

Controlled Release of Macromolecules

$407,004
Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2008 · EB

Identification of cancer neoepitope-specific T cells using novel high-throughput hydrogel based platforms

$406,871
Jonathan P Schneck · Johns Hopkins University · R33 · FY2025 · CA

Mechanisms of PAK1 activation, signaling and tumor resistance

$406,839
Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA

KLF9-TXNRD2 axis in melanoma progression and metastasis

$406,791
Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA

KLF9-TXNRD2 axis in melanoma progression and metastasis

$406,791
Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA

Define the role of POT1 mutations in genome instability and cancer

$406,771
Agnel Sfeir · New York University School Of Medicine · U01 · FY2018 · CA

UV damage, repair, and mutagenesis

$406,742
Gerd P Pfeifer · Beckman Research Institute/City Of Hope · R37 · FY2011 · ES

UV damage, repair, and mutagenesis

$406,742
Gerd P Pfeifer · Beckman Research Institute/City Of Hope · R37 · FY2012 · ES

The Framingham School Nevus Study

$406,682
Allan C Halpern · Sloan-Kettering Inst Can Research · R01 · FY2007 · AR

Controlled Release of Macromolecules

$406,614
Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2009 · EB

High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.

$406,500
Shenglong Zhang · Directseq Biosciences, Inc. · R41 · FY2024 · HG

Core D: Pathology and BioImaging

$406,464
Carl D Morrison · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA

Delivery of GPNMB Therapeutics for Bone Regeneration

$406,394
Moses O Oyewumi · Northeast Ohio Medical University · R01 · FY2024 · AR

KLF9-TXNRD2 axis in melanoma progression and metastasis

$406,373
Mikhail Nikiforov · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA

The integrated stress response and the microenvironment in melanoma progression

$406,333
Constantinos Koumenis · University Of Pennsylvania · R01 · FY2023 · CA

Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma

$406,291
Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2019 · CA

Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory

$406,288
Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA

Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy

$406,274
Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2022 · CA

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$406,274
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Decoding mechanisms of phenotypic memory in single cells

$406,250
Sydney Shaffer · University Of Pennsylvania · DP5 · FY2023 · OD

Decoding mechanisms of phenotypic memory in single cells

$406,250
Sydney Shaffer · University Of Pennsylvania · DP5 · FY2021 · OD

Decoding mechanisms of phenotypic memory in single cells

$406,250
Sydney Shaffer · University Of Pennsylvania · DP5 · FY2022 · OD

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$406,240
Beverly A. Mock · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA